FORERUNNER PHARMA RESEARCH CO.,LTD.

Chugai Pharmaceutical Co., Ltd. (“Chugai”) and National Cancer Center Japan is conducting a joint research selected for “Funding for research to expedite effective drug discovery by Government, Academia and Private partnership (GAPFREE)” project led by the AMED. Forerunner Pharma Research Co., Ltd., a wholly owned subsidiary of Chugai, is leading the joint research in collaboration with National Cancer Center Japan, other academic research centers and Chugai to promote drugs research and development on cancers.

Contact address

• National Cancer Center Research Institute
• Tusukiji 5-1-1, Chuo-ku, Tokyo 104-0045
• natoriosm●chugai-pharm.co.jp (● replace to ＠)
• URL：www.forerunner-pharma.co.jp